Related Experiment Video
Updated: Jun 10, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Small-molecule modulators of c-Myc/Max and Max/Max interactions
1Institute of Organic Chemistry, University of Leipzig, Johannisallee 29, Leipzig, Germany. tberg@uni-leipzig.de
Abstract:
The transcription factor c-Myc is overexpressed in many tumors in human beings and has been identified as a highly promising target for cancer therapy. Most biological functions of c-Myc require heterodimerization with its activation partner Max. Inhibition of the protein-protein interactions between c-Myc and Max by small molecules has been shown to be a feasible and powerful approach toward the inhibition of c-Myc functions. More recently, stabilization of Max homodimers to reduce the amount of Max available for activating c-Myc has also been demonstrated to counteract Myc activity. This review summarizes our current knowledge on small organic molecules that inhibit c-Myc by modulating protein-protein interactions relevant for the biological function of this important oncoprotein.
Insights
Small molecules targeting the transcription factor c-Myc offer a promising cancer therapy. These compounds inhibit c-Myc by disrupting its interaction with Max or stabilizing Max homodimers, counteracting tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- The transcription factor c-Myc is frequently overexpressed in human tumors.
- c-Myc's oncogenic functions rely on heterodimerization with its partner, Max.
- Targeting c-Myc protein-protein interactions presents a viable strategy for cancer treatment.
Purpose of the Study:
- To review small organic molecules that inhibit c-Myc.
- To summarize approaches modulating c-Myc/Max protein-protein interactions.
- To highlight therapeutic strategies against c-Myc in cancer.
Main Methods:
- Literature review of small molecules targeting c-Myc.
- Analysis of compounds inhibiting c-Myc/Max heterodimerization.
- Summary of strategies stabilizing Max homodimers.
Main Results:
- Small molecules can effectively inhibit c-Myc/Max interactions.
- Stabilization of Max homodimers reduces c-Myc activity.
- Diverse small organic molecules show potential in modulating these interactions.
Conclusions:
- Targeting c-Myc protein-protein interactions is a key strategy in cancer therapy.
- Small molecules offer a feasible approach to inhibit oncogenic c-Myc.
- Modulating c-Myc/Max interactions holds promise for developing novel cancer treatments.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Inhibitors of Viral Protein Synthesis
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

